HF
AQST icon

HRT Financial’s Aquestive Therapeutics AQST Stock Holding History

HRT Financial’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-994,966
Closed -$6.43M – 3746
2025
Q4 		$6.43M Buy
994,966
+434,757
+78% +$2.71M 0.02% 660
2025
Q3 		$3.13M Buy
+560,209
New +$2.42M 0.01% 908
2025
Q2 		– Sell
-16,048
Closed -$46K – 2564
2025
Q1 		$46K Sell
16,048
-26,128
-62% -$79.1K ﹤0.01% 2244
2024
Q4 		$150K Buy
+42,176
New +$194K ﹤0.01% 1994
2024
Q2 		– Sell
-285,360
Closed -$1.22M – 2185
2024
Q1 		$1.22M Buy
+285,360
New +$950K 0.01% 795
2021
Q3 		– Sell
-49,907
Closed -$198K – 3249
2021
Q2 		$198K Buy
+49,907
New +$199K ﹤0.01% 2391
2021
Q1 		– Sell
-19,521
Closed -$104K – 2662
2020
Q4 		$104K Buy
+19,521
New +$117K ﹤0.01% 1629

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HRT Financial's AQST Position: Q1 2026 in Review

HRT Financial sold out of Aquestive Therapeutics (AQST) in Q1 2026, closing a stake of 994,966 shares — an estimated $6.43M sold.

HRT Financial first reported a position in AQST in Q4 2020 and held it in 7 quarters. The position peaked at $6.43M in Q4 2025. 179 funds tracked by Wall St. Rank hold AQST as of Q1 2026.

  • HRT Financial reported no remaining Aquestive Therapeutics position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 994,966 Aquestive Therapeutics shares in Q1 2026, an estimated $6.43M.
  • HRT Financial first reported a position in Aquestive Therapeutics in Q4 2020 and held it in 7 quarters.
  • HRT Financial's Aquestive Therapeutics position peaked at $6.43M in Q4 2025.
  • 179 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.